Newfin Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Kukatpally, Hyderabad, Telangana, India, established in 1996.
1996 Kukatpally, Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Newfin Pharmaceuticals Private Limited

Newfin Pharmaceuticals Private Limited, a active private limited company, was established on 17 January 1996 in Kukatpally, Hyderabad, Telangana, India. Engaging in chemical products within the manufacturing sector, it holds CIN: U24239TG1996PTC022898. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.

It upholds a compliant status. Its leadership includes Suresh Adapa (Additional Director), Tamma Sandhya Rani (Additional Director). Past directors included Suresh Adapa, Bonthu Aruna, Bonthu Venkata Reddy. It holds ₹3.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 6-3, Sterling Emerald,Plot No.118, Bhagyanagar Colony,, Kukatpally, Hyderabad, Telangana.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TG1996PTC022898

  • Registration Number

    022898

  • Incorporation Date

    17 January 1996

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹1.50 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 1.50 M
  • Company Age 30 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 3.00 M
  • Revenue Growth **** -25.37%
  • Profit Growth **** -1485.30%
  • Ebitda **** -117.38%
  • Net Worth -5.17%
  • Total Assets -30.74%
Company report

Newfin Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Newfin Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Newfin Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Suresh Adapa Additional Director 25 Aug 2015 Current
Tamma Sandhya Rani Additional Director 01 Jul 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 24 Jan 2011 Past
Pramod Abcsdd Additional Director 30 Sep 2011 Past
Pramod Abcsdd Managing Director 03 Nov 2015 Past
Pramod Abcsdd Director 20 Jun 2009 Past
Pramod Abcsdd Managing Director 16 Jul 2011 Past
Pramod Abcsdd Director 24 Jan 2011 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Newfin Pharmaceuticals.

Newfin Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 25.37% decrease. The company also saw a substantial fall in profitability, with a 1485.3% decrease in profit. The company's net worth dipped by a decrease of 5.17%.

Newfin Pharmaceuticals revenue growth over time
Newfin Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -25.37%
*******
*******
*******
*******
Revenue from Operations
*******
 -27.38%
*******
*******
*******
*******
Total Assets
*******
 -30.74%
*******
*******
*******
*******
Profit or Loss
*******
 -1485.30%
*******
*******
*******
*******
Net Worth
*******
 -5.17%
*******
*******
*******
*******
EBITDA
*******
 -117.38%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Newfin Pharmaceuticals?

In 2017, Newfin Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹3,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Sbi : 0.30 Cr
Latest Charge Details
Date Lender Amount Status
24 Jul 2003 Sbi ₹1.00 M Open
02 Dec 1996 Sbi ₹2.00 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Newfin Pharmaceuticals?

Unlock and access historical data on people associated with Newfin Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Newfin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Newfin Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Newfin Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Newfin Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Newfin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.

  • Director Appointment

    The activity Tamma Sandhya Rani was appointed as a Additional Director was appointed as a Additional Director on 01 Jul 2016 & has been associated with this company since 9 years 8 months . was completed.

  • Director Appointment

    The activity Suresh Adapa was appointed as a Additional Director was appointed as a Additional Director on 25 Aug 2015 & has been associated with this company since 10 years 6 months . was completed.

  • Charges

    The activity A charge with Sbi amounted to Rs. 1.00 M with Charge ID 90117840 was registered on 24 Jul 2003. was completed.

  • Charges

    Progress on A charge with Sbi amounted to Rs. 2.00 M with Charge ID 90117177 was registered on 02 Dec 1996. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Newfin Pharmaceuticals Private Limited?

The CIN of Newfin Pharmaceuticals Private Limited is U24239TG1996PTC022898.

Where is Newfin Pharmaceuticals Private Limited headquartered?

Newfin Pharmaceuticals Private Limited is headquartered at 6-3, Sterling Emerald,Plot No.118, Bhagyanagar Colony,, Kukatpally, Hyderabad, Telangana.

When was Newfin Pharmaceuticals Private Limited incorporated?

Newfin Pharmaceuticals Private Limited was incorporated on 17 January 1996.

Who are the current directors of Newfin Pharmaceuticals Private Limited?

The current directors of Newfin Pharmaceuticals Private Limited are

What is the primary industry of Newfin Pharmaceuticals Private Limited?

The primary industry of Newfin Pharmaceuticals Private Limited is Manufacturing.

Is Newfin Pharmaceuticals Private Limited a listed company?

Newfin Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Newfin Pharmaceuticals Private Limited?

The authorized capital of Newfin Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.

What is the compliance status of Newfin Pharmaceuticals Private Limited?

The compliance status of Newfin Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available